Coronary artery bypass grafting in a patient with myasthenia gravis. 2014

Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
Department of Cardiovascular Surgery, Beylikduzu Kolan Hospital.

A 70-year-old male patient with myasthenia gravis required coronary artery bypass grafting due to triple-vessel disease. The anesthetic management was performed with general anesthesia using reduced doses of muscle relaxants. He was extubated four hours after surgery and the postoperative course was uneventful. Coronary artery bypass surgery in myasthenic patients can be challenging to anesthesiologists and cardiac surgeons. In this rare condition, a meticulous assessment of the patient's neurologic and cardiac status, and careful perioperative anesthetic management were needed in order to avoid life-threatening complications in both intraoperative and postoperative periods.

UI MeSH Term Description Entries
D007430 Intraoperative Care Patient care procedures performed during the operation that are ancillary to the actual surgery. It includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests. Care, Intraoperative
D008297 Male Males
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000768 Anesthesia, General Procedure in which patients are induced into an unconscious state through use of various medications so that they do not feel pain during surgery. Anesthesias, General,General Anesthesia,General Anesthesias
D001026 Coronary Artery Bypass Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion. Aortocoronary Bypass,Bypass, Coronary Artery,Bypass Surgery, Coronary Artery,Coronary Artery Bypass Grafting,Coronary Artery Bypass Surgery,Aortocoronary Bypasses,Artery Bypass, Coronary,Artery Bypasses, Coronary,Bypass, Aortocoronary,Bypasses, Aortocoronary,Bypasses, Coronary Artery,Coronary Artery Bypasses

Related Publications

Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
November 2014, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
January 2000, The Kurume medical journal,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
January 2020, Annals of cardiac anaesthesia,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
June 2015, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
November 2006, Georgian medical news,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
June 2003, Middle East journal of anaesthesiology,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
February 2006, The Annals of thoracic surgery,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
April 1995, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
April 1994, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
Tolga Demir, and Murat Ugurlucan, and Fatma Bahceci, and Hale Bolgi Demir, and Selma Sezer
January 2005, HIV medicine,
Copied contents to your clipboard!